Kolon TissueGene, Inc.
Developing cell and gene therapies for orthopedic and degenerative disorders.
950160 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 9713 Key West Ave Suite 300, Rockville
- Website:
- https://www.tissuegene.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, disease-modifying allogeneic cell therapy for the treatment of knee osteoarthritis. This innovative therapy is designed to reduce pain, improve joint function, and potentially slow disease progression. Kolon TissueGene is advancing TG-C through late-stage clinical trials and exploring the application of its platform technology for other degenerative conditions, such as spinal diseases.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Kolon TissueGene, Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-12 00:00 |
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
|
Korean | 88.5 KB | |
| 2025-09-11 00:00 |
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 20.0 KB | |
| 2025-09-10 00:00 |
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 13.9 KB | |
| 2025-09-09 00:00 |
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 19.1 KB | |
| 2025-09-04 00:00 |
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 18.6 KB | |
| 2025-08-27 00:00 |
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 18.7 KB | |
| 2025-08-14 00:00 |
Capital/Financing Update
파생상품거래손실발생
|
Korean | 7.8 KB | |
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.3 MB | |
| 2025-07-28 00:00 |
Share Issue/Capital Change
[기재정정]전환청구권행사
|
Korean | 13.1 KB | |
| 2025-07-24 00:00 |
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 20.3 KB | |
| 2025-07-22 00:00 |
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 16.7 KB | |
| 2025-07-14 00:00 |
Regulatory News Service
[기재정정]투자판단관련주요경영사항 (기술수출 계약 체결(당사의 라이센시인 코오롱생명과학㈜ 주요경영사항))
|
Korean | 17.9 KB | |
| 2025-07-11 00:00 |
Share Issue/Capital Change
[기재정정]전환청구권행사 (제2회차)
|
Korean | 11.8 KB | |
| 2025-07-10 00:00 |
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 16.2 KB | |
| 2025-07-10 00:00 |
Share Issue/Capital Change
전환청구권행사 (제2회차)
|
Korean | 8.7 KB |
Automate Your Workflow. Get a real-time feed of all Kolon TissueGene, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Kolon TissueGene, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
